Results 121 to 130 of about 194,523 (350)

Harnessing Algal Biorefineries for Waste to Wealth Paradigm: A Pathway Toward Circular and Sustainable Bioeconomy

open access: yesCleanMat, EarlyView.
This review highlights the use of wastewater from various sources including industrial, municipal, and agricultural effluents for microalgal cultivation. It emphasizes on the integrated approach of wastewater treatment and microalgal biomass production for high value‐added bioproducts such as biofuels, animal feed, biofertilizers, bioplastics while ...
Prachi Bhatnagar   +3 more
wiley   +1 more source

METABOLISM OF ARACHIDONIC ACID IN PHOSPHOLIPID

open access: yesThe Keio Journal of Medicine, 1966
After albino rats were starved or fed with the fat and pyridoxine deficient diet, linoleic, linolenic and arachidonic acids and pyridoxine were administered. The amount of polyunsaturated fatty acids in phospholipid of the liver and muscle was then determined and the following results were obtained.1) Even if rats were fed on the fat deficient diet or ...
openaire   +3 more sources

Design, Synthesis, and Biological Characterization of Macromolecular Ester Prodrugs of a Selective Cyclooxygenase‐2 Inhibitor

open access: yesChemMedChem, EarlyView.
Two macromolecular ester prodrugs of a COX‐2 inhibitor are designed and synthesized. They are based on two different oligo(ethylene glycol) spacers linking the COX‐2 inhibitor to hyaluronic acid. The spacers are designed to differ in the sensitivity to the hydrolytic conditions.
Mario Saletti   +13 more
wiley   +1 more source

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia   +2 more
wiley   +1 more source

Dapagliflozin alleviates high‐fat‐induced obesity cardiomyopathy by inhibiting ferroptosis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1358-1373, April 2025.
Abstract Aim: Dapagliflozin (Dapa) is a novel hypoglycaemic agent with multiple cardiovascular protective effects, and it is widely used in treatment of heart failure patients, but whether it can improve obese phenotype of heart failure and its mechanism is still unclear.
Di Chen   +7 more
wiley   +1 more source

Studies relating to Polyunsaturated Fatty Acid (PUFA) Supplementation and Fertility in Cattle [PDF]

open access: yes, 2007
End of project reportReproductive inefficiency has a significant impact on the economic performance of both dairy and beef herds, particularly in seasonal calving systems. Nutrition plays a fundamental role in reproduction. Furthermore, there is emerging
Childs, Stuart   +3 more
core  

Circulating oxylipins predict mortality in heart failure with preserved ejection fraction

open access: yesESC Heart Failure, EarlyView.
A targeted LC–MS lipidomics approach identified arterial 15‐keto PGF2a as associated with 5‐year mortality in 90 patients with HFpEF. Abstract Aims Heart failure with preserved ejection fraction (HFpEF) poses significant diagnostic, prognostic and therapeutic challenges, with high morbidity and mortality rates.
Vaishnavi Aradhyula   +12 more
wiley   +1 more source

Intestinal microbiome alterations in pediatric epilepsy: Implications for seizures and therapeutic approaches

open access: yesEpilepsia Open, EarlyView.
Abstract The intestinal microbiome plays a pivotal role in maintaining host health through its involvement in gastrointestinal, immune, and central nervous system (CNS) functions. Recent evidence underscores the bidirectional communication between the microbiota, the gut, and the brain and the impact of this axis on neurological diseases, including ...
Teresa Ravizza   +4 more
wiley   +1 more source

Arachidonic Acid Pathway Members PLA2G7, HPGD, EPHX2, and CYP4F8 Identified as Putative Novel Therapeutic Targets in Prostate Cancer [PDF]

open access: bronze, 2011
Paula Vainio   +13 more
openalex   +1 more source

Home - About - Disclaimer - Privacy